QCLS has been in the news 750% more than usual
Dec 04, 2025, 5:34 PM
-42.90%
What does QCLS do
MyMD Pharmaceuticals, based in Baltimore, develops drug products for aging, autoimmune diseases, and chronic pain, focusing on two platforms: MYMD-1 for inflammation and Supera-CBD for pain and addiction. The company went public in 2008 and employs nine people.
QCLS has been in the news recently: Q/C Technologies Inc. (NASDAQ: QCLS) received a significant investment from Martin Shkreli, who set a price target of $100 for the company's stock. The company reported a 15% increase in revenue, attributed to strong sales from its new product line in the last quarter.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.